T1	Participants 164 227	patients with chronic heart failure after myocardial infarction
T2	Participants 364 396	patients with heart failure (HF)
T3	Participants 560 618	patients with class II to IV HF and ejection fraction <35%
T4	Participants 770 888	Of 330 patients intended for enrollment, 23 were randomized (MARVEL-1) before stopping the study for financial reasons
T5	Participants 1426 1480	HF patients with chronic postinfarction cardiomyopathy
T6	Participants 1791 1837	HF patients with postinfarction cardiomyopathy
